← Back
Oric Pharmaceuticals
ORIC · listed on Nasdaq · worth $931.84 million
$8.99
−3.33% on Oct 29
No insider bought Oric Pharmaceuticals stock in the last year. They sold it 15 times, $1.91 million in all.
Red dot = an insider sold◆ = company newsA number = that many on nearby days · click a mark to see who, or read the filing
The shares anyone can buy and sell, leaving out those held by insiders and big long-term owners.
88.7M shares
86% of all shares
Shares borrowed and sold by investors who expect the price to drop.
Company insiders
In the last year, four insiders sold Oric Pharmaceuticals stock and none bought. Nine of the 15 sales are marked on the filing as planned in advance; most by company executives. The biggest seller was Dominic Piscitelli, Chief Financial Officer.
Planned sales
Form 144 notices filed for Oric Pharmaceuticals in recent months, beside the Form 4 sales reported after each. A notice says a person intends to sell; it is not a sale.
Director Richard A. Heyman filed to sell 7,600 shares on 1 Oct; no sale reported yet10b5-1 plan adopted 26 Sep 2025 · Notice on SEC.gov
Director Richard A. Heyman filed to sell 8,100 shares on 1 Oct; sold 6,700 by 1 Oct10b5-1 plan adopted 26 Sep 2025 · Notice on SEC.gov
CFO Dominic Piscitelli filed to sell 229,500 shares on 26 Aug; sold 28,000 by 20 Oct10b5-1 plan adopted 26 May 2026 · Notice on SEC.gov
All reports
Every insider trade and SEC report we hold for Oric Pharmaceuticals.
Newest first
ReportedTradeInsiderOf their holdingShares @ priceValue
Oct 21SoldDominic PiscitelliOct 21 · Traded Oct 20 · Chief Financial Officer · A trade scheduled ahead of time under a written plan, so its timing was set before the day it happened.14,000 @ $13.53$189.4K
Oct 2SoldRichard A. HeymanOct 2 · Traded Oct 1 · Director · A trade scheduled ahead of time under a written plan, so its timing was set before the day it happened.via a trust or family3,200 @ $12.91$41.3K
Oct 2SoldRichard A. HeymanOct 2 · Traded Oct 1 · Director · A trade scheduled ahead of time under a written plan, so its timing was set before the day it happened.3,500 @ $12.91$45.2K
Sep 29SoldDominic PiscitelliSep 29 · Traded Sep 28 · Chief Financial Officer · A trade scheduled ahead of time under a written plan, so its timing was set before the day it happened.13,400 @ $13.53$181.3K
Sep 25SoldDominic PiscitelliSep 25 · Traded Sep 24 · Chief Financial Officer · A trade scheduled ahead of time under a written plan, so its timing was set before the day it happened.500 @ $13.51$6.8K
27 more with Pro →Analysts, earnings and news
Analysts' price target
$20.67 average
12 analysts
Analysts' opinions, which tend to run optimistic. Not our forecast or advice.
Profit vs what was expected
2 of 4 quarters above
Q2 '26−$0.38 a share−$0.02
Q1 '26−$0.34 a share−$0.02
Q4 '25−$0.30 a share+$0.07
Q3 '25−$0.33 a share+$0.07